Beta Cell Death and Protection
- 1 November 2003
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1005 (1) , 32-42
- https://doi.org/10.1196/annals.1288.005
Abstract
Type 1 diabetes is an immune-mediated disease critically dependent upon the interaction between antigen-presenting cells and T cells. Clearly, both CD4+ and CD8+ T cells are required, but activated CD4+ T cells are both necessary and sufficient in causing disease. The mechanism of the Th1/Th2 immunoregulatory imbalance is unclear and needs to be further investigated. CD8+ T cells are not commonly sufficient in causing disease, but CD8 T cells are necessary in initiation (14 weeks) effector phase of the disease. It is still unclear whether the CD8+ T cell exerts its function as a classical effector cell or mainly as an immunomodulatory cell acting in synergy with the CD4+ T cell. The relative role of T cell effector mechanisms such as Fas/FasL, perforin/granzyme, and the TRAIL systems is unclear. Proinflammatory cytokines, reactive oxygen species, and other immune mediators seem to be involved in beta cell destruction, but much is to be learned about signaling, molecular mechanisms, and in vivo importance.Keywords
This publication has 33 references indexed in Scilit:
- Suppressor of Cytokine Signaling-1 Regulates the Sensitivity of Pancreatic β Cells to Tumor Necrosis FactorPublished by Elsevier ,2002
- Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes MellitusNew England Journal of Medicine, 2002
- Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissuesPublished by Elsevier ,1999
- Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta- induced cytotoxicity and reduces nitric oxide production.Journal of Clinical Investigation, 1998
- Human pancreatic islet beta-cell destruction by cytokines is independent of nitric oxide productionJournal of Clinical Endocrinology & Metabolism, 1994
- Interleukin 1β induces diabetes and fever in normal rats by nitric oxide via induction of different nitric oxide synthasesCytokine, 1994
- In situ islet cytokine gene expression during development of type I diabetes in the non-obese diabetic mouseImmunology Letters, 1994
- Nicotinamide treatment in the prevention of insulin‐dependent diabetes mellitusDiabetes/Metabolism Research and Reviews, 1993
- Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.Journal of Clinical Investigation, 1992
- A Prospective Study of the Development of Diabetes in Relatives of Patients with Insulin-Dependent DiabetesNew England Journal of Medicine, 1990